Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

CorroHealth

Explore full profile

Clinically-led analytics and technology for healthcare revenue cycle

Plano, United StatesFounded 2020Other B2B Software
Valuation $100–250M Last recorded · 2023
Revenue $500M–1B Latest reported FY
Headcount 5–10k Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for CorroHealth and the history behind them.

About CorroHealth

CorroHealth provides clinically-led healthcare analytics and technology-driven solutions designed to improve the financial performance of hospitals, health systems, and health plans. The company was formed in 2020 through the merger of four organizations: TrustHCS, Visionary RCM, T-System, and RevCycle+. This strategic consolidation was aimed at offering a comprehensive suite of services to navigate the complexities of the healthcare financial landscape. The company is led by CEO Pat Leonard, a seasoned executive with extensive experience in healthcare leadership at companies like McKesson and Change Healthcare.

CorroHealth's business model centers on providing end-to-end revenue cycle management (RCM). This includes a wide array of services such as patient experience optimization, chargemaster services, utilization management, clinical documentation integrity (CDI), medical coding, and claims management. The company leverages artificial intelligence and automation to streamline workflows, reduce operational costs, and enhance accuracy for its clients. Key proprietary technologies include the VISION platform for clinical validation and PULSE, an AI-driven medical coding automation platform. Revenue is generated by providing these technology-driven services and solutions to its client base of healthcare providers and payers.

Since its inception, CorroHealth has pursued a strategy of growth through acquisitions to broaden its service offerings. Notable acquisitions include TCP Services and Analytics (2020) to enhance its AI and clinical documentation capabilities , Aergo Solutions (2022) for denial management expertise , Versalus Health (2022) for deeper analytics and regulatory leadership , and the major acquisition of Xtend Healthcare from Navient in 2024 for $365 million, which added significant scale and patient engagement capabilities. CorroHealth is primarily backed by private equity firms, with The Carlyle Group being a majority investor since its formation. In late 2024, Patient Square Capital made a strategic investment, joining Carlyle in sharing joint control of the company.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2020
Headquarters
Plano, United States
Employees
7,756
Open positions
26
Dealroom signal
92.5/100
Industry
Enterprise Software
Sector
Other B2B Software
Business model
SaaS
Client focus
b2b
Investment activity
4 companies, latest Jun 2025
Capital deployed
$0
Preferred round
ACQUISITION

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Jun 2025 $0 — SANTECHTURE ↗
GROWTH EQUITY VCOther financing Oct 2024 $0 — The Carlyle Group · Patient Square Capital · TT Capital Partners · Sanaka Group ↗
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

CorroHealth website traffic

Latest recorded traffic for CorroHealth is 100K monthly website visits, up 203% over the last three months. CorroHealth's team grew 0% over the past year.

Latest monthly visits100K 3-month web change+203% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later5 investors entered at this stage

  • The Carlyle Group
  • Patient Square Capital
  • TT Capital Partners
  • Sanaka Group
  • SANTECHTURE
Team profiled 20 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 7 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
16 countries with
team presence
🇮🇳 India83%
🇺🇸 United States15.6%
🇦🇪 United Arab Emirates0.6%
🇬🇧 United Kingdom0.1%
🇶🇦 Qatar0.1%
Top 5 of 16 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about CorroHealth on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CorroHealth’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.